Tenon MedicalTNON
About: Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Employees: 27
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.82% less ownership
Funds ownership: 2.46% [Q1] → 1.64% (-0.82%) [Q2]
21% less funds holding
Funds holding: 14 [Q1] → 11 (-3) [Q2]
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
62% less capital invested
Capital invested by funds: $322K [Q1] → $122K (-$200K) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for TNON.
Financial journalist opinion
Based on 6 articles about TNON published over the past 30 days









